Dieters turn their backs on Fen-Phen and Redux
'You're gonna die ... don't take those pills'
September 12, 1997
Web posted at: 6:58 p.m. EDT (2258 GMT)
LOS ANGELES (CNN) -- There was a time when the diet drug
combination popularly known as Fen-Phen and another known as
Redux were so popular that pharmacists could scarcely keep
them in stock. But no longer.
In the wake of warnings from the U.S. Food and Drug
Administration that the drugs may cause heart problems, there
has been a precipitous drop-off in consumption.
Fenfluramine and phentermine (Fen-Phen) work by altering
brain chemistry to make people feel full after eating less.
But the FDA issued a warning after a Mayo Clinic study linked
the combination to rare heart-valve defects in 80 Fen-Phen
patients.
There has been at least one death linked to the drug. In
July, the wife of North Miami Beach's mayor suffered a fatal
heart attack that doctors blame, in part, on Fen-Phen.
The Journal of the American Medical Association reported that
Redux and another diet drug, Pondimin, were associated with
brain dysfunctions in animals, and could cause pulmonary
hypertension.
Earlier this week, the Florida State Board of Medicine banned
Fen-Phen for 90 days until it could devise strict rules for
its use.
Dieters don't need to be warned twice
Thousands, perhaps millions of people, have already made the
decision to stop using the drugs.
"Most people I know won't touch the stuff any more," says one
woman. "That's it -- over and done with."
"I said forget this stuff," says another. "I'm not gonna do
this anymore. It's just making me a nervous wreck. I can do
that on my own without a drug."
Bel-Air pharmacist Bob Zuckerman says Fen-Phen and Redux used
to disappear rapidly from the shelves, but not now.
"We're lucky if we see one or two a day," he says, "where we
used to see 10 to 15 a day."
Author of Redux book now seldom prescribes it
Some weight-loss centers -- including Nutrisystem -- have
also stopped offering Fen-Phen and Redux.
And, while many doctors have become very conservative about
writing prescriptions for the drugs, many patients also have
stopped asking for them.
According to Dr. Mortimer Maxwell of UCLA, "Our census
decreased markedly over the last four to six months, because
all the media, including TV, ran stories on primary pulmonary
hypertension and then lately on heart disease. So people got
phone calls from friends that said 'You're gonna die ...
don't take those pills.'"
A new report from IMS America researchers shows that weekly
prescriptions for Redux have fallen 52 percent since
February. Prescriptions for fenfluramine have dropped 63
percent.
And the doctor who wrote the book "The Redux Revolution" says
he won't prescribe Redux unless a patient has obesity-related
health problems.
While Fen-Phen and Redux are in decline, pharmaceutical
companies are developing new diet drugs they hope will fare
better than their celebrated predecessors.
Correspondent Linda Ciampa contributed to this report.